Monitor for future prospectus supplements that would signal an actual offering; absence of immediate pricing or sale details means no direct financial impact yet.
ORKA drugs
ORKA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 13 $61.38entry
- T+1 · 7mo ago +9.25%α +8.04% · $67.06
- T+5 · 7mo ago +12.20%α +8.91% · $68.87
- T+20 · 6mo ago +7.01%α −0.72% · $65.68
- T+60 · 4mo ago +37.50%α +28.58% · $84.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Oruka Therapeutics' $1 billion shelf registration (S-3) has become effective, allowing the company to sell common stock, preferred stock, depositary shares, or warrants from time to time. This creates a potential for future dilution, though no immediate offering has been announced.
Key Facts
- S-3 shelf registration effective as of April 10, 2026
- Registration allows for up to $1 billion in securities to be offered
- Securities may include common stock, preferred stock, depositary shares, or warrants
- Offerings can occur at any time over the next three years, with terms disclosed in future prospectus supplements
Financial Impact
Up to $1 billion in potential future dilution
Risk Factors
- Potential share dilution if and when offerings are executed
- Market perception of equity overhang could pressure stock price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001154 |
| Document: 9999999995-26-001154-index.html | 9999999995-26-001154 |
| Document: 9999999995-26-001154.txt | 9999999995-26-001154 |
Track record
40 reports on ORKA
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers